logo
Plus   Neg
Share
Email

ImmunityBio Reports Data From Its COVID-19 Vaccine Candidate In Healthy Phase 1 Study Participants

ImmunityBio, Inc. (IBRX) reported initial data indicating that a single subcutaneous injection of the company's COVID-19 vaccine candidate in healthy phase 1 clinical study participants stimulated the generation of T cells that are reactive to the spike and nucleocapsid protein antigens delivered by the vaccine. The mean T cell levels seen in the vaccinated participants were equivalent to those for patients recovered from infection by the virus.

The company noted that 14-16 days after the single dose, the mean level of T cells generated in response to the hAd5 S+N T cell vaccine were ten times higher for N specific T cells. By day 21, both S and N T cell responses achieved levels ten times higher as compared to pre-vaccination levels, the company noted.

"These data further validate the path we have taken in designing our vaccine candidate to target both the S and N proteins in order to increase T cell responses," said Patrick Soon-Shiong, Founder and Executive Chairman of ImmunityBio.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Church & Dwight Co., Inc. is recalling select vitafusion gummy products due to isolated manufacturing issue, the U.S. Food and Drug Administration said. The recall was initiated after the company's investigation of two consumer reports identified the possible presence of a metallic mesh material in product lots manufactured in a four-day period between October 29 and November 3, 2020. Shares of Netflix Inc. (NFLX) tanked 10% in extended trading session on Tuesday after the online-video streaming giant's first-quarter subscriber additions fell short of expectations. Netflix added 3.98 million subscribers globally in the quarter, far below its forecast of 6.00 million, to end the... Tech giant Apple Inc. (AAPL) on Tuesday held its first product launch event of the year and unveiled new iMac and iPad Pro, which are powered by the latest M1 chips. The Cupertino, California-based company also unveiled AirTag, a lost-device tracking gadget, and an upgraded Apple TV 4K with a new...
Follow RTT